Paroxysmal hypertensive crises induced by selegiline in a patient with Parkinson's disease

被引：13

作者：

Ito, D ^{[1
]}

Amano, T ^{[1
]}

Sato, H ^{[1
]}

Fukuuchi, Y ^{[1
]}

机构：

[1] Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo 1608582, Japan

来源：

JOURNAL OF NEUROLOGY | 2001年 / 248卷 / 06期

关键词：

D O I：

10.1007/s004150170168

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：533 / 534

页数：2

共 14 条

[1] Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease [J].

Churchyard, A ;

Mathias, CJ ;

Boonkongchuen, P ;

Lees, AJ .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 63 (02) :228-234

[2]

Churchyard A, 1999, MOVEMENT DISORD, V14, P246, DOI 10.1002/1531-8257(199903)14:2<246::AID-MDS1008>3.0.CO

[3]

2-P

[4] A REVIEW OF THE PHARMACOLOGY OF SELEGILINE [J].

HEINONEN, EH ;

LAMMINTAUSTA, R .

ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 :44-59

[5] Safety of selegiline (deprenyl) in the treatment of Parkinson's disease [J].

Heinonen, EH ;

Myllyla, V .

DRUG SAFETY, 1998, 19 (01) :11-22

[6]

HOFFMAN BB, 1990, PHARMACOL BASIS THER, P87

[7] POTENTIAL FLUOXETINE SELEGILINE INTERACTION [J].

JERMAIN, DM ;

HUGHES, PL ;

FOLLENDER, AB .

ANNALS OF PHARMACOTHERAPY, 1992, 26 (10) :1300-1300

[8] PSEUDO-PHEOCHROMOCYTOMA AFTER MULTIPLE-DRUG INTERACTIONS INVOLVING THE SELECTIVE MONOAMINE-OXIDASE INHIBITOR SELEGILINE [J].

LEFEBVRE, H ;

NOBLET, C ;

MORRE, N ;

WOLF, LM .

CLINICAL ENDOCRINOLOGY, 1995, 42 (01) :95-98

[9] Monoamine oxidase inhibitors - An update on drug interactions [J].

Livingston, MG ;

Livingston, HM .

DRUG SAFETY, 1996, 14 (04) :219-227

[10]

MCGRATH PJ, 1989, J CLIN PSYCHOPHARM, V9, P310

← 1 2 →